SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950142-14-000302
Filing Date
2014-02-07
Accepted
2014-02-07 16:15:21
Documents
2
Group Members
AISLING CAPITAL II LPAISLING CAPITAL PARTNERS LLCAISLING CAPITAL PARTNERS LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G eh1400265_13g-esperion.htm SC 13G 218309
2 EXHIBIT 1 eh1400265_ex01.htm EX-99 19909
  Complete submission text file 0000950142-14-000302.txt   239885
Mailing Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Aisling Capital II LP (Filed by) CIK: 0001350778 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-862-4840
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87536 | Film No.: 14584503
SIC: 2834 Pharmaceutical Preparations